Brace Treatment for Idiopathic Scoliosis; PReventing Idiopathic SCOliosis PROgression
PRISCOPRO
3D Designed Boston Brace Versus Standard Boston Brace in Halting Progression in Idiopathic Scoliosis: a Randomized Controlled Trial
1 other identifier
interventional
170
1 country
2
Brief Summary
Idiopathic scoliosis is the most common spinal deformity in children and adolescents with an estimated prevalence of 3%. About one tenth of the children with scoliosis develop a deformity that requires treatment with brace or surgery with the current treatment protocol. When brace treatment for scoliosis is indicated, standard treatment consists of bracing 20 hours or more per day. Outcomes of brace treatment depend to a large extent on wearing time and since many adolescents feel uncomfortable in the brace, it is of importance to combine efficacy and comfortability of the brace.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2021
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 13, 2021
CompletedFirst Posted
Study publicly available on registry
March 18, 2021
CompletedStudy Start
First participant enrolled
April 30, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 1, 2037
February 21, 2025
February 1, 2025
6.3 years
March 13, 2021
February 20, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Curve progression
Increase in curve severity (Cobb angle) of more than 6 degrees on two consecutive radiographs after baseline
Measured at each six-month follow-up until skeletal maturity. Skeletal maturity defined as less than 1 cm body height increase in 6 months.
Secondary Outcomes (6)
Clinical outcomes
At each six-month follow-up and 2, 5, 10 years after skeletal maturity
Patient-reported outcome measures
At each six-months follow-up and 2, 5, 10 years after skeletal maturity
Patient-reported outcome measures
At each six-month follow-up, and 2, 5, 10 years after skeletal maturity
Patient-reported outcome measures
At each six-month follow-up, and 2, 5, 10 years after skeletal maturity
Patient-reported outcome measures
At each six-month follow-up, and 2, 5, 10 years after skeletal maturity
- +1 more secondary outcomes
Study Arms (2)
3D TLSO
EXPERIMENTALA 3-dimensional Boston brace will be designed to the patient's individual type of scoliosis. In-brace radiographs will be performed after prescription. Reinforcement of the assigned intervention will be performed in conjunction with reassessment every 6 months. Patients are encouraged to use the brace for 20 hours per day and to also continue with physical activities for the entirety of the study. Compliance will be monitored with a heat sensor built in the brace that measures wearing time.
Standard TLSO
ACTIVE COMPARATORA standard Boston brace will be designed to the patient's individual type of scoliosis. In brace radiographs will be performed after prescription. Reinforcement of the assigned intervention will be performed in conjunction with reassessment every 6 months. Patients are encouraged to use the brace for 20 hours per day and to also continue with physical activities for the entirety of the study. Compliance will be monitored with a heat sensor built in the brace that measures wearing time.
Interventions
Brace treatment with Boston 3D 20 hours a day until skeletal maturity.
Brace treatment with standard Boston brace 20 hours a day until skeletal maturity.
Eligibility Criteria
You may qualify if:
- Cobb 25-40 degrees
- Skeletally immature, Sanders score of 6 or less and Risser 2 or less.
- Menarche status maximum one year in females
- Aged 9-17 years
- No previous brace treatment or surgery for scoliosis
- Apex of the primary curve at T7 or caudal
You may not qualify if:
- Non-idiopathic scoliosis (i.e. neuromuscular, syndromic or congenital scoliosis)
- Previous spine surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Karolinska Institutetlead
- Linkoeping Universitycollaborator
Study Sites (2)
Linköping university hospital
Linköping, Sweden
Karolinska university hospital
Stockholm, Sweden
Related Publications (1)
Diarbakerli E, Charalampidis A, Abbott A, Gerdhem P. PReventing Idiopathic SCOliosis PROgression (PRISCOPRO): A protocol for a quadruple-blinded, randomized controlled trial comparing 3D designed Boston brace to standard Boston brace. PLoS One. 2021 Aug 9;16(8):e0255264. doi: 10.1371/journal.pone.0255264. eCollection 2021.
PMID: 34370760DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Elias Diarbakerli, PT, PhD
Karolinska Institutet
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Orthotist and research nurse will know what type of brace the participant receives, but will not tell the participant which type he/she has received. Investigators, care providers and outcome assessors will be blinded for type of brace.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 13, 2021
First Posted
March 18, 2021
Study Start
April 30, 2021
Primary Completion (Estimated)
September 1, 2027
Study Completion (Estimated)
April 1, 2037
Last Updated
February 21, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- The study protocol will be submitted to a peer-reviewed journal.
- Access Criteria
- The investigators in charge will be responsible for reviewing access requests. Crude data, randomization procedures and intervention details can be shared with other researchers upon request.
IPD underlying published manuscripts will be accessible for other researchers.